Asbury, NJ, United States of America

Imants Liepins

USPTO Granted Patents = 4 

 

Average Co-Inventor Count = 3.6

ph-index = 1

Forward Citations = 6(Granted Patents)


Company Filing History:


Years Active: 2017-2021

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: Imants Liepins: Innovator in Calcium Phosphate Compositions

Introduction

Imants Liepins is a notable inventor based in Asbury, NJ (US), recognized for his contributions to the field of biomedical engineering. He holds a total of 4 patents, focusing on innovative solutions for porous structures and fixation devices.

Latest Patents

Among his latest patents, Liepins has developed curable calcium phosphate compositions designed for use with porous structures. These compositions include calcium phosphate and a perfusion modifier, providing a versatile solution for various applications. Additionally, he has patented methods for utilizing these compositions in conjunction with porous structures, which can include biocompatible metal coatings. Another significant patent involves the creation of porous screws and pegs, which are manufactured through additive techniques to enhance bone ingrowth. These devices are designed to maintain effective engagement with bone while offering improved porosity.

Career Highlights

Throughout his career, Imants Liepins has worked with prominent companies in the biomedical sector, including Zimmer GmbH and B-One Ortho, Corp. His work has significantly impacted the development of medical devices that facilitate better integration with biological tissues.

Collaborations

Liepins has collaborated with esteemed professionals in his field, including John Chernosky and Bradford J. Coale. These partnerships have contributed to the advancement of his innovative projects and patents.

Conclusion

Imants Liepins stands out as a key figure in the development of advanced biomedical solutions, particularly in the realm of calcium phosphate compositions and fixation devices. His work continues to influence the industry and improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…